Minneapolis-based Smiths Medical announces the launch of the Acapella choice blue vibratory positive expiratory pressure (PEP) therapy system. Acapella is designed to aid in the removal of secretions for patients who have cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.

Vibratory PEP therapy is a drug-free supplemental treatment that can reduce COPD flare-ups and hospital length of stay by 1.5 days.The Acapella choice blue system is designed to:

  • Effectively deliver medication when combined with a nebulizer
  • Achieve PEP in any position, whether sitting, standing, lying down or Trendelenburg
  • Allow patients to easily adjust the resistance level to meet their therapeutic needs
  • Be disassembled for easy cleaning and disinfection in a variety of ways, including in the dishwasher

“The introduction of the Acapella choice blue therapy system enhances the quality of life for those living with chronic respiratory conditions,” says Tom Wortham, RRT, clinical consultant for Smiths Medical. “These conditions are often characterized by frequent trips to the emergency department, hospitalizations, and significant impact on the daily activities of living.” 

Wortham adds, “The Acapella choice blue system is a solution designed to meet the needs of these patients and positively impact their quality of life by decreasing hospital length of stay and exacerbations of their disease.”